State Street’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.11B | Buy |
26,296,399
+304,875
| +1% | +$25.1M | 0.07% | 241 |
|
|
2025
Q4 | $2.22B | Buy |
25,991,524
+371,892
| +1% | +$30.5M | 0.07% | 223 |
|
|
2025
Q3 | $1.99B | Sell |
25,619,632
-14,746
| -0.1% | -$1.15M | 0.07% | 242 |
|
|
2025
Q2 | $2B | Sell |
25,634,378
-149,084
| -0.6% | -$11.1M | 0.08% | 235 |
|
|
2025
Q1 | $1.87B | Sell |
25,783,462
-25,160
| -0.1% | -$1.8M | 0.08% | 239 |
|
|
2024
Q4 | $1.91B | Sell |
25,808,622
-457,011
| -2% | -$32M | 0.08% | 231 |
|
|
2024
Q3 | $1.73B | Buy |
26,265,633
+256,538
| +1% | +$18.6M | 0.07% | 255 |
|
|
2024
Q2 | $2.4B | Sell |
26,009,095
-766,690
| -3% | -$67.9M | 0.11% | 170 |
|
|
2024
Q1 | $2.56B | Sell |
26,775,785
-179,865
| -0.7% | -$15.1M | 0.11% | 163 |
|
|
2023
Q4 | $2.06B | Buy |
26,955,650
+507,914
| +2% | +$35.3M | 0.1% | 196 |
|
|
2023
Q3 | $1.83B | Sell |
26,447,736
-605,568
| -2% | -$48.7M | 0.1% | 189 |
|
|
2023
Q2 | $2.55B | Buy |
27,053,304
+108,102
| +0.4% | +$9.4M | 0.13% | 144 |
|
|
2023
Q1 | $2.23B | Sell |
26,945,202
-355,964
| -1% | -$28M | 0.13% | 154 |
|
|
2022
Q4 | $2.04B | Buy |
27,301,166
+493,844
| +2% | +$38.1M | 0.12% | 170 |
|
|
2022
Q3 | $2.22B | Sell |
26,807,322
-90,807
| -0.3% | -$8.74M | 0.14% | 144 |
|
|
2022
Q2 | $2.56B | Sell |
26,898,129
-23,657
| -0.1% | -$2.45M | 0.15% | 134 |
|
|
2022
Q1 | $3.17B | Buy |
26,921,786
+1,073
| +0% | +$120K | 0.16% | 124 |
|
|
2021
Q4 | $3.49B | Buy |
26,920,713
+948,638
| +4% | +$111M | 0.17% | 116 |
|
|
2021
Q3 | $2.94B | Buy |
25,972,075
+252,381
| +1% | +$28.8M | 0.16% | 120 |
|
|
2021
Q2 | $2.66B | Sell |
25,719,694
-7,197
| -0% | -$678K | 0.14% | 130 |
|
|
2021
Q1 | $2.15B | Sell |
25,726,891
-134,815
| -0.5% | -$11.4M | 0.12% | 158 |
|
|
2020
Q4 | $2.36B | Sell |
25,861,706
-893,253
| -3% | -$74.1M | 0.14% | 134 |
|
|
2020
Q3 | $2.14B | Sell |
26,754,959
-493,061
| -2% | -$38.5M | 0.15% | 137 |
|
|
2020
Q2 | $1.88B | Buy |
27,248,020
+251,299
| +0.9% | +$17.9M | 0.14% | 151 |
|
|
2020
Q1 | $1.7B | Buy |
26,996,721
+245,928
| +0.9% | +$17.7M | 0.15% | 139 |
|
|
2019
Q4 | $2.08B | Buy |
26,750,793
+363,555
| +1% | +$28.4M | 0.14% | 146 |
|
|
2019
Q3 | $1.93B | Sell |
26,387,238
-134,115
| -0.5% | -$9.42M | 0.14% | 157 |
|
|
2019
Q2 | $1.63B | Sell |
26,521,353
-70,788
| -0.3% | -$4.28M | 0.12% | 173 |
|
|
2019
Q1 | $1.7B | Buy |
26,592,141
+1,108,641
| +4% | +$63.3M | 0.13% | 155 |
|
|
2018
Q4 | $1.3B | Sell |
25,483,500
-96,522
| -0.4% | -$4.88M | 0.12% | 172 |
|
|
2018
Q3 | $1.48B | Buy |
25,580,022
+860,043
| +3% | +$42.1M | 0.11% | 176 |
|
|
2018
Q2 | $1.2B | Sell |
24,719,979
-411,204
| -2% | -$19.2M | 0.1% | 199 |
|
|
2018
Q1 | $1.17B | Sell |
25,131,183
-1,006,992
| -4% | -$43.7M | 0.1% | 204 |
|
|
2017
Q4 | $982M | Sell |
26,138,175
-392,376
| -1% | -$14.4M | 0.08% | 260 |
|
|
2017
Q3 | $967M | Sell |
26,530,551
-778,593
| -3% | -$29.7M | 0.08% | 252 |
|
|
2017
Q2 | $1.08B | Sell |
27,309,144
-857,838
| -3% | -$31.3M | 0.1% | 219 |
|
|
2017
Q1 | $883M | Buy |
28,166,982
+473,532
| +2% | +$14.8M | 0.08% | 263 |
|
|
2016
Q4 | $865M | Buy |
27,693,450
+1,229,697
| +5% | +$39.8M | 0.08% | 260 |
|
|
2016
Q3 | $1.06B | Buy |
26,463,753
+579,039
| +2% | +$21.8M | 0.11% | 208 |
|
|
2016
Q2 | $861M | Sell |
25,884,714
-1,304,847
| -5% | -$44.6M | 0.09% | 240 |
|
|
2016
Q1 | $799M | Sell |
27,189,561
-375,441
| -1% | -$10.4M | 0.09% | 245 |
|
|
2015
Q4 | $726M | Buy |
+27,565,002
| New | +$716M | 0.08% | 264 |
|
|
2015
Q2 | – | Sell |
-28,961,760
| Closed | -$688M | – | 3731 |
|
|
2015
Q1 | $688M | Sell |
28,961,760
-667,656
| -2% | -$15M | 0.07% | 291 |
|
|
2014
Q4 | $629M | Buy |
29,629,416
+1,507,872
| +5% | +$30.3M | 0.06% | 313 |
|
|
2014
Q3 | $479M | Buy |
28,121,544
+375,342
| +1% | +$5.92M | 0.05% | 357 |
|
|
2014
Q2 | $397M | Sell |
27,746,202
-199,800
| -0.7% | -$2.71M | 0.04% | 410 |
|
|
2014
Q1 | $345M | Sell |
27,946,002
-1,297,278
| -4% | -$15M | 0.04% | 429 |
|
|
2013
Q4 | $321M | Buy |
29,243,280
+247,020
| +0.9% | +$2.78M | 0.04% | 446 |
|
|
2013
Q3 | $337M | Buy |
28,996,260
+147,948
| +0.5% | +$1.73M | 0.04% | 418 |
|
|
2013
Q2 | $323M | Buy |
+28,848,312
| New | +$341M | 0.04% | 405 |
|
Other funds holding EW
VCM
VPM
State Street's EW Position: Q1 2026 in Review
State Street increased its Edwards Lifesciences (EW) stake by 1.2% in Q1 2026, buying an estimated $25.1M and bringing the position to 26,296,399 shares worth $2.11B. The position accounts for 0.07% of the portfolio, ranked #241.
State Street first reported a position in EW in Q2 2013 and has held it in 50 quarters since. The position peaked at $3.49B in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- State Street held 26,296,399 shares of Edwards Lifesciences worth $2.11B as of Q1 2026.
- State Street bought 304,875 Edwards Lifesciences shares in Q1 2026, an estimated $25.1M.
- Edwards Lifesciences made up 0.07% of State Street's portfolio in Q1 2026, its #241 holding.
- State Street first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 50 quarters since.
- State Street's Edwards Lifesciences position peaked at $3.49B in Q4 2021.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.